Related Experiment Video
Updated: May 25, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Correction of endothelial dysfunction in patients with arterial hypertension
M A Soloviev1, N V Kulakova, T A Semiglazova
1Institute of Pharmacology, Siberian Division of Russian Academy of Medical Sciences, Tomsk, Russia.
Abstract:
We examined 38 patients (mean age 55.92 ± 1.56 years) with a 3-5-year history of arterial hypertension. The study showed that hypertension is accompanied by endothelial dysfunction and one of its forming factors is activation of the inflammatory response. Highly sensitive diagnostic tests can verify initiation of inflammation in preclinical manifestations. The use of nonsteroidal anti-inflammatory drugs, irrespective of the tropism to cyclooxygenase forms, alleviates manifestations of endothelial dysfunction in patients with arterial hypertension.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Atherosclerosis III: Management
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Vasodilators
